Cite
APA Citation
Frasco, M. A., Shih, T., Incerti, D., Diaz Espinosa, O., Vania, D. K., & Thomas, N. (2017). incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a. Journal of medical economics, 20, 1074–1082. http://access.bl.uk/ark:/81055/vdc_100049476100.0x000035